Evidence map›Paper›PMID 41497076›Full record

ReviewAnnals of medicine and surgery (2012)2026

Multidrug-resistant tuberculosis (MDR-TB): an evolving threat to the Nigerian health system - a review.

Aminu Shehu, Malik Olatunde Oduoye, Araj Naveed Siddiqui, Hareem Shaikh, Janice Odhiambo, Muhammad Muhsin, Abdullahi Zainab Zubairu, Chidiogo Ezenwoba, Ahmad Abdulhadi, Chrispin Biamba and 10 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Aminu ShehuCollege of Natural and Pharmaceutical Sciences, Bayero University Kano, Kano State, Nigeria.
Malik Olatunde OduoyeDepartment of Research, Medical Research Circle, Goma, DR Congo.ORCID https://orcid.org/0000-0001-9635-9891
Araj Naveed SiddiquiDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Hareem ShaikhDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Janice OdhiamboSchool of Pharmacy, University of Nairobi, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-0374-7666
Muhammad MuhsinCollege of Natural and Pharmaceutical Sciences, Bayero University Kano, Kano State, Nigeria.
Abdullahi Zainab ZubairuCollege of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
Chidiogo EzenwobaFaculty of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.
Ahmad AbdulhadiCollege of Natural and Pharmaceutical Sciences, Bayero University Kano, Kano State, Nigeria.
Chrispin BiambaDepartment of Research, Medical Research Circle, Goma, DR Congo.ORCID https://orcid.org/0000-0002-5592-0854
Laiba ShakeelDepartment of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.ORCID https://orcid.org/0009-0007-0840-9803
Amidu AlhassanCollege of Health and Allied Sciences, School of Nursing and Midwifery, University of Cape Coast, Cape Coast, Ghana.ORCID https://orcid.org/0000-0002-4102-4995
Adolphe KaregeyaCollege of Nursing, University of Utah, Utah, USA.ORCID https://orcid.org/0009-0000-2749-7510
Mc Juan Muco MugishaClinical Research Department, Rinda Ubuzima Research Organization, Kigali, Rwanda.ORCID https://orcid.org/0009-0002-9949-5017
Calvin R WeiDepartment of Research and Development, Shing Huei Group, Taipei, Taiwan.
Freddy ZihindulaFaculty of Medicine, Evangelic University in Africa, Bukavu, DR Congo.
Eric Buchangende NdaganoEcole de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgium.ORCID https://orcid.org/0000-0002-3980-2129
Thierry Nasibu NtumbaFaculty of Medicine, Catholic University of Sapientia of Goma, Goma, DR Congo.
Christian TagueDepartment of Research, Medical Research Circle, Goma, DR Congo.ORCID https://orcid.org/0009-0004-8547-3153
Aymar AkilimaliDepartment of Research, Medical Research Circle, Goma, DR Congo.ORCID https://orcid.org/0000-0001-9393-1215

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant tuberculosis (MDR-TB) is an increasing public health issue that threatens the efforts in the treatment and control of tuberculosis (TB) worldwide, including in Nigeria. According to the World Health Organization, there were 558 000 MDR-TB cases globally in 2019. Nigeria, being the most populous country in Africa, is said to carry a larger proportion of MDR-TB in the world. If not addressed promptly, many Nigerian populations will continue to suffer from MDR-TB, which could result in increased morbidity and mortality rates. Eliminating the threat of MDR-TB in Nigeria requires a multifaceted approach that combines national and international efforts. These approaches should be centered on the molecular testing of MDR-TB using line probe assays and GeneXpert MTB/RIF technology, which enables early and efficient diagnosis of

Indexed as

antitubercular agentshumansmultidrug-resistantMycobacterium tuberculosisNigeriatuberculosisWorld Health Organization

Identifiers

PMID41497076
PMCPMC12768143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.